Michael Siluk/UCG/Universal Images Group via Getty Images; BI
- Companies can't afford to pay for weight-loss shots for all their workers who qualify.
- But Novo Nordisk, the maker of Wegovy, is penalizing employers for partially restricting access.
- So two employers in Texas and North Carolina scrapped weight-loss drug coverage altogether.
There's a little-known reason more companies aren't paying for their workers' weight-loss shots.
Sure, the drugs cost a lot. For many employers, paying for the $1,000-a-month shots for the vast numbers of workers with obesity or overweight could put them out of business.